The system is used to successfully treat circulatory issues, all types of acute and chronic pain, long-term (intractable) pain and drug-resistant pain. The neoGEN® also offers specific-parameter signaling for efficacious neuromuscular reeducation, muscle strengthening and relaxation of muscle spasm activity.
The RST-Sanexas neoGEN® medical device is the original and only electric cell signaling device that was used in clinical research, published in multiple medical journals proving the ability to effect nerves and reduce painful symptoms associated with peripheral neuropathy.
More than 30 published medical reports are available by written request covering painful neuropathic conditions, and muscular neuromuscular reeducation. RST-Sanexas neoGEN® system is safe, effective, user-friendly and reimbursed, even by Medicare.
Applications and Electric Cell Signaling protocols have been subjected to clinical trails. The results have been published in numerous academic, scientific and medical publications and literature. The technologies efficacy is amply demonstrated by these published results and is reinforced anecdotally, through the testimonials of thousands of patients.
We need a nice verbatuam placed in here that promotes the value of the system and the benefits that they have seen in their practice and within their patient population.
- Peter M. Carney, M.D., F.A.A.NS
Electric cell signaling treatment (EcST) refers to the use of electronic signal energy waves produced by an ultra-high digital frequency generator (UHdfg). These therapeutic pulsed energy waves are comfortably and non-invasively delivered directly into the body’s desired anatomical region.
The neoGEN® system has numerous published medical journal reports and studies involving the successful treatment of multiple medical indications, syndromes and neurogenic pain conditions.
The neoGEN® system is the original (and only) EcST medical system that was clinically utilized with the documented and published Combined Electrochemical Treatment (CET) protocol.